Melanotan II

Melanotan II (MT-2) is a synthetic cyclic heptapeptide analog of alpha-melanocyte stimulating hormone (α-MSH). This research-grade peptide has been extensively studied for its interaction with melanocortin receptors, particularly MC1R, MC3R, MC4R, and MC5R in laboratory settings. Melanotan II is utilized as a tool compound in laboratory research to investigate melanogenesis, melanocortin receptor signaling, and related physiological pathways. All discussion herein is limited to experimental research contexts and does not imply applied, therapeutic, or physiological use.

Melanotan II is employed in laboratory research to study melanocortin receptor pharmacology and melanogenesis. Common experimental applications include receptor binding assays, melanocyte stimulation studies, and melanocortin pathway investigations. Research protocols utilize Melanotan II to investigate the structure-activity relationships of melanocortin peptides and their interactions with the five melanocortin receptor subtypes in various cell culture and animal models.

Mechanistically, Melanotan II activates melanocortin receptors, which are G-protein coupled receptors that signal through adenylyl cyclase activation. MC1R activation in melanocytes leads to increased cAMP, PKA activation, and CREB-mediated transcription of melanogenic enzymes including tyrosinase, TRP-1, and TRP-2. The peptide's interaction with central MC3R and MC4R in the hypothalamus involves pathways related to energy balance and feeding behavior in preclinical research models. These central effects are mediated through neuronal circuits in the arcuate nucleus and paraventricular nucleus.

Preclinical investigations of Melanotan II include in-vitro receptor binding studies and in-vivo animal models evaluating melanogenesis and melanocortin receptor activation. Reported findings include increased eumelanin production, enhanced melanocyte proliferation, and characterization of receptor subtype selectivity. Animal studies explore the peptide's interactions with multiple melanocortin receptor subtypes and downstream signaling cascades. All findings are interpreted strictly within the context of laboratory research models.